Stocks to watch, August 24: Natco Pharma, M&M, RIL, Senco Gold, Caplin Point, real estate stocks, Grasim

The domestic stock market is expected to open with notable gains on Monday, August 24. The GIFT NIFTY futures suggest that the NIFTY50 index will open 94 points higher.

The resolution was passed with the requisite majority on August 20.

The proposed expansion could enable RIL to enter or scale up in the chemicals, fertilisers and explosives value chain. However, the new MoA clause is subject to approval from the Registrar of Companies.

The decline could be positive for oil marketing companies (OMCs) such as IOC, BPCL and HPCL, as lower crude prices can ease their input costs, while aviation, paints and tyre stocks could also benefit from reduced fuel and raw-material costs.

Meanwhile, ONGC and Oil India may remain sensitive to the movement in crude prices, given their exposure to upstream oil realisations.

"This expansion is expected to add to the company's revenue, which we expect to grow by over 25%, making it around ₹10,500-₹11,000 crore this financial year. In FY26, the company clocked ₹8,430 crore revenue," Sen added.

As per the NSE filings, Kaynes Technology signed the MoU with Bosgame to expand the company’s presence in the Indian market.

The deal aims to collaborate using Bosgame’s product innovation and intelligent computing portfolio with Kaynes Tech’s capabilities in electronics design, engineering, integrated manufacturing, testing, supply-chain management and lifecycle support.

As per the NSE data, NTPC Renewable Energy Ltd, which is a wholly owned subsidiary of NTPC Green Energy, emerged as one of the successful bidders in the e-reverse auction conducted by Solar Energy Corporation of India (SECI).

The tender order was for the selection of RE Power Developers for Assured Peak Supply of 6,000 megawatt-hours (MWh).

Grasim, the holding company of the flagship Aditya Birla Group firms such as UltraTech Cement, Aditya Birla Capital, Birla Opus, Aditya Birla Renewables and Birla Pivot, had reported its "highest-ever" consolidated revenue of ₹1.75 lakh crore in FY26.

Grasim, which will complete 80 years of incorporation on August 25, now operates 10 business lines and has a "market capitalisation exceeding ₹2 trillion", Birla said on Friday at the holding firm's 79th annual general meeting.

He said the composition of Grasim's earnings is becoming increasingly balanced, with established businesses generating strong cash flows even as newer growth engines scale up rapidly.

According to data compiled from investor presentations, total combined sales bookings, or pre-sales, of the 28 major listed real estate companies stood at ₹39,964 crore in the first quarter of 2026-27 compared to ₹50,900 crore in the year-ago period.

The housing segment contributed the bulk of the sales booking numbers.

Godrej Properties became the largest listed real estate developer in terms of sales bookings. The company sold properties worth ₹8,651 crore in the June quarter against ₹7,082 crore in the year-ago period.

Out of 28, 19 developers have reported growth in pre-sales.

They are Godrej Properties, Lodha, Sobha, Max Estates, Puravankara, Kalpataru, Embassy Developments, Mahindra Lifespace, Raymond Realty, Sunteck Realty, Kolte-Patil, Shriram Properties, Ajmera Realty, Arvind SmartSpaces, TARC, Sri Lotus Developers, Arihant Superstructures, Arkade and Suraj Estate.

"Gold loan is safe lending for banks...it is not a consumption loan, but mostly it is income-generating and also helps small businesses to grow. Last year, we saw very significant growth of 30% in the segment due to a jump in gold prices. It will be slower this year as there is a 30% decline in gold prices," Indian Bank MD and CEO Binod Kumar told PTI in an interaction.

This growth would come from tonnage, he said, adding that the gold loan segment is likely to grow about 20%.

Currently, the gold loan portfolio is around ₹1.25 lakh crore, and the book should exceed ₹1.5 lakh crore during this financial year at the anticipated growth rate, he said.

SBI came into existence on July 1, 1955, through an Act of Parliament, which, among other things, provided for the transfer of the undertaking of the Imperial Bank of India.

The country's biggest lender crossed the landmark of ₹100 lakh crore in total business, which is an aggregate of total loans and advances in the second quarter of the last financial year. This further increased to ₹110.01 lakh crore at the end of June 2026.

Recently, the company unveiled its pickup 'Mahindra Scorpio Lifestyler ', which will hit the market in India in April 2027, and it will be launched as the 'Mahindra Lifestyler' in global markets.

"The Lifestyler pickup was developed as a global platform for access, mainly leveraging a global opportunity...It is an important part of our global growth strategy. We have been outlining that the 'Lifestyler' will be an important part of our global growth strategy," he said.

Earlier this month, the Securities Appellate Tribunal stayed a SEBI order to debar ZEEL for two months and its CEO Punit Goenka for one year from capital markets in the Hyderabad land pledge case.

The Preferential Issue and Allotment Committee approved the allotment on August 21, following the extraordinary general meeting nod on July 31 and in-principle approvals from the NSE and BSE dated July 27, besides a Securities Appellate Tribunal order dated August 14, the company said in a regulatory filing.

Qualcomm Ventures, through its affiliate Qualcomm Asia Pacific Pte Ltd, offloaded 75 lakh equity shares, representing a 1.28% stake in Bengaluru-based Shadowfax Technologies, according to the bulk deal data on the BSE.

The shares were disposed of at an average price of ₹245.13 apiece, taking the deal size to ₹183.85 crore.

Qualcomm Ventures is the investment arm of US-based chip major Qualcomm.

Following the latest transaction, Qualcomm Ventures' holding in Shadowfax fell to nearly 1% from 2.26%.

Details of the buyers of Shadowfax Technologies' shares could not be ascertained on the exchange. ** Caplin Point Laboratories**: The pharma company said the United States Food and Drug Administration (US FDA) conducted an unannounced inspection of Caplin Steriles’ injectable and ophthalmic manufacturing facility located at Gummidipoondi.

The inspection was conducted between August 13, 2026, and August 21, 2026. At the end of the inspection, the Company received Form 483 with 10 observations.

The observations are procedural in nature and do not pertain to data integrity, and none of them were repeat observations, it said.

Auro Peptides Ltd is a subsidiary/business arm of the company.

Aurobindo Pharma added that the inspection concluded with one observation, relating to facility and equipment maintenance. This observation does not pertain to data integrity or related GMP compliance.

"Upon conclusion of the inspection, the company has been issued a Form 483 with 4 (Four) observations. The company believes that the observations are procedural in nature and is confident of addressing these observations comprehensively within stipulated timelines," it added.